(19)
(11) EP 1 470 420 A2

(12)

(88) Date of publication A3:
13.11.2003

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03710699.4

(22) Date of filing: 21.01.2003
(51) International Patent Classification (IPC)7G01N 33/53, G01N 33/567, C12P 21/06, C12P 21/04, C12N 1/20, C12N 5/00, C12N 5/02, C12N 15/00, C12N 15/74, C07K 1/00, C07K 16/00, A01N 37/18
(86) International application number:
PCT/US2003/001694
(87) International publication number:
WO 2003/061365 (31.07.2003 Gazette 2003/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE SI TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 23.01.2002 US 351006 P
09.05.2002 GB 0210597

(71) Applicant: Aventis Pharmaceuticals Inc.
Bridgewater, New Jersey 08807-2854 (US)

(72) Inventors:
  • EISHINGDRELO, Haifeng
    Montville, NJ 07045 (US)
  • CAI, Jidong
    Whippany, NJ 07981 (US)
  • SANDRASAGRA, Anthony
    Princeton, NJ 08540 (US)

(74) Representative: Bouvet, Philippe et al
Aventis Pharma S.A.Direction des Brevets,Tri LEO/14420, avenue Raymond Aron
92165 Antony Cedex
92165 Antony Cedex (FR)

   


(54) A NUCLEIC ACID ENCODING A G-PROTEIN-COUPLED RECEPTOR, AND USES THEREOF